
A bioengineering team devised techniques for feasibly adding cancer-killing enzymes to engineered immune cells that in lab mice kill solid-tumor and blood cancer cells. . . . → Read More: Nanotech Enzyme Process Boosts T-Cell Cancer Therapies
|
|||||
![]() A bioengineering team devised techniques for feasibly adding cancer-killing enzymes to engineered immune cells that in lab mice kill solid-tumor and blood cancer cells. . . . → Read More: Nanotech Enzyme Process Boosts T-Cell Cancer Therapies ![]() A California state research agency is funding preclinical development of a gel designed to regenerate stem cells in the skin to help heal venous skin ulcers. . . . → Read More: Grant Funds Regenerative Gel for Treating Skin Ulcers ![]() A new company formed by a technology venture investor and the Mayo Clinic aims to produce and supply more readily available radiation drug therapies. . . . → Read More: Start-Up to Manufacture, Supply Practical Radiation Drugs ![]() A collaboration between university researchers and a space science company is designing a stem cell research lab on a proposed commercial space station. . . . → Read More: Stem Cell Lab Planned for Commercial Space Station ![]() An executive order issued by President Joe Biden yesterday seeks to make biotechnology and biomanufacturing a centerpiece of the American economy. . . . → Read More: Exec. Order Aims to Boost U.S. Biotech, Manufacturing ![]() A joint venture with business development and bio-manufacturing companies aims to build new cell and gene therapy businesses to advance treatments from Mayo Clinic labs. . . . → Read More: Venture to Build Cell, Gene Therapy Businesses ![]() A new enterprise using digital and synthetic biology to create sustainable chemicals at industrial scale is raising $5 million in pre-seed round funds. . . . → Read More: Synthetic Bio Chemicals Start-Up Gains $5M in Early Funds ![]() A developer of synthetic biology tools and components is acquiring a biological materials developer for its automation assets as the biotechnology industry consolidates. . . . → Read More: Ginkgo Acquires Biomaterials Maker as Industry Consolidates ![]() A clinical trial is set to begin testing engineered immune-system cells designed to precisely target and infiltrate cancerous tumors without other potentially toxic proteins. . . . → Read More: Trial Okayed for Engineered Cell Cancer Therapy ![]() A biotechnology company creating targeted antibacterial and microbiome treatments aided by gene editing is raising $35 million in new venture funds. . . . → Read More: Precision Antibacterial Company Raises $35M in New Funds |
|||||
Copyright © 2023 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |